Cellebrite promotes a complete end‑to‑end Investigative Digital Intelligence Platform covering collection, review, analysis, and management of digital evidence from mobile, computers, cloud, and open‑source data, signaling a strategic evolution from point forensics tools to integrated investigative platforms.

Cellebrite maintains a robust global footprint with offices and operational hubs across North America, Europe, Asia‑Pacific, and Latin America, including locations in Israel, the US (Vienna, VA and Parsippany, NJ), UK, Germany, Brazil, India, Japan, Australia, and Singapore, indicating sustained international expansion and market penetration.

Cellebrite DI Ltd. is publicly traded on Nasdaq under the ticker CLBT and reported a valuation of approximately $2.4 billion at the time of its 2021 public listing, reflecting strong investor confidence and access to capital markets.

Cellebrite’s press kit cites more than 6,000 public safety customers, over 2,000 private enterprise customers, and presence in 150+ countries, evidencing extensive customer traction and entrenched market adoption across law enforcement, military, and enterprise sectors.

Cellebrite emphasizes legally sanctioned investigations and lawful access, implying adherence to compliance and evidentiary standards typical of public safety and judicial environments, although specific certifications are not enumerated in the available materials.

External monitoring groups highlight Cellebrite’s provision of hacking and digital intelligence tools to police, prison, immigration authorities, and repressive regimes, indicating reputational and regulatory risk that could constrain certain market segments or lead to divestment campaigns.

Cellebrite’s primary operational and commercial headquarters in Parsippany, New Jersey, alongside its Israeli corporate headquarters in Petah Tikva, suggests a dual‑hub operational model tailored to both US and global public‑sector markets.